Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes

Endocrine

Volumn 53, Issue 1, 2016, Pages 220-226

  Bellastella, Giuseppe ^a   Maiorino, Maria Ida ^a   De Bellis, Annamaria ^a   Vietri, Maria Teresa ^a   Mosca, Carmela ^a   Scappaticcio, Lorenzo ^a   Pasquali, Daniela ^a   Esposito, Katherine ^a   Giugliano, Dario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Glycemic variability; Salivary cortisol; Serum cortisol; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADRENAL FUNCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVA LEVEL; AGED; BLOOD; CHEMISTRY; CIRCADIAN RHYTHM; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SALIVA;

ADULT; AGED; BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; SALIVA;

EID: 84945586591     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0777-5     Document Type: Article

References (30)

1. G. Mazziotti, C. Gazzaruso, A. Giustina, Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol. Metab. 22, 499–506 (2011)
2. K. Esposito, G. Bellastella, M.I. Maiorino, R. Pivonello, A. Colao, D. Giugliano, Cushing syndrome, metabolic syndrome and inflammation: a suggested way out. Rev. Endocrinol. Metab. 1, 41–45 (2013)
3. T. Krarup, T. Krarup, C. Hagen, Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing’s syndrome? Diabetes Metab. Res. Rev. 28, 219–227 (2012)
4. B. Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin, P. Roger, A. Tabarin, Occult Cushing’s syndrome in type-2 diabetes. J. Clin. Endocrinol. Metab. 88, 5808–5813 (2003)
5. G. Reimondo, A. Pia, B. Allasino, F. Tassone, S. Bovio, G. Borretta, A. Angeli, M. Terzolo, Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin. Endocrinol. (Oxf) 67, 225–229 (2007)
6. I. Chiodini, M. Torlontano, A. Scillitani, M. Arosio, S. Bacci, S. Di Lembo, P. Epaminonda, G. Augello, R. Enrini, B. Ambrosi, G. Adda, V. Trischitta, Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur. J. Endocrinol. 153, 837–844 (2005)
7. A. Gungunes, M. Sahin, T. Demirci, B. Ucan, E. Cakir, M.S. Arslan, I.O. Unsal, B. Karbek, M. Calıskan, M. Ozbek, E. Cakal, T. Delibasi, Cushing’s syndrome in type 2 diabetes patients with poor glycemic control. Endocrine 47, 895–900 (2014)
8. S. Newsome, K. Chen, J. Hoang, J.D. Wilson, J.M. Potter, P.E. Hickman, Cushing’s syndrome in a clinic population with diabetes. Intern. Med. J. 38, 178–182 (2008)
9. H. Raff, J.L. Raff, J.W. Findling, Late-night salivary cortisol as a screening test for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 83, 2681–2686 (1998)
10. M. Trilck, J. Flitsch, D.K. Lüdecke, R. Jung, S. Petersenn, Salivary cortisol measurement–a reliable method for the diagnosis of Cushing’s syndrome. Exp. Clin. Endocrinol. Diabetes 113, 225–230 (2005)
11. H. Raff, Update on late-night salivary cortisol for the diagnosis of Cushing’s syndrome: methodological considerations. Endocrine 44(2), 346–349 (2013). doi:10.1007/s12020-013-0013-0
12. V. Bansal, N. El Asmar, W.R. Selman, B.M. Arafah, Pitfalls in the diagnosis and management of Cushing’s syndrome. Neurosurg. Focus 38, E4 (2015)
13. G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–5602 (2003)
14. L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)
15. E.M. Poll, I. Kreitschmann-Andermahr, Y. Langejuergen, S. Stanzel, J.M. Gilsbach, A. Gressner, E. Yagmur, Saliva collection method affects predictability of serum cortisol. Clin. Chim. Acta 382, 15–19 (2007)
16. L.D. Dorn, J.F. Lucke, T.L. Loucks, S.L. Berga, Salivary cortisol reflects serum cortisol: analysis of circadian profiles. Ann. Clin. Biochem. 44, 281–284 (2007)
17. M.S. Karpman, M. Neculau, V.C. Dias, G.A. Kline, Defining adrenal status with salivary cortisol by gold-standard insulin hypoglycemia. Clin. Biochem. 46, 1442–1446 (2013)
18. E.O. Melin, M. Thunander, M. Landin-Olsson, M. Hillman, H.O. Thulesius, Depression, smoking, physical inactivity and season independently associated with midnight salivary cortisol in type 1 diabetes. BMC Endocr. Disord. 14, 75 (2014)
19. R.A. Hackett, A. Steptoe, M. Kumari, Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. J. Clin. Endocrinol. Metab. 99, 4625–4631 (2014)
20. J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, M. Besser, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 43, 545–550 (1995)
21. H.M. Kronenberg, S. Melmed, K.S. Polonsky, P. Reed Larsen, Williams Textbook of Endocrinology, 11th edn. (Elsevier, Saunders, 2007). ISBN 1416029117
22. N.R. Hill, N.S. Oliver, P. Choudhary, J.C. Levy, P. Hindmarsh, D.R. Matthews, Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol. Ther. 13, 921–928 (2011)
23. F. Picconi, A. Di Flaviani, I. Malandrucco, I. Giordani, S. Frontoni, Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. Nutr. Metab. Cardiovasc. Dis. 22, 691–696 (2012)
24. J. Smith-Palmer, M. Brändle, R. Trevisan, M. Orsini, S. Federici, L.W. Valentine, Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes. Diabetes Res. Clin. Pract. 105, 273–284 (2014)
25. C.M. McDonnell, S.M. Donath, S.I. Vidmar, G.A. Werther, F.J. Cameron, A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol. Ther. 7, 253–263 (2005)
26. E. Standl, O. Schnell, A. Ceriello, Postprandial hyperglycemia and glycemic variability: should we care? Diabetes Care 34, S120–S127 (2011)
27. M. Stolar, Glycemic control and complications in type 2 diabetes mellitus. Am. J. Med. 123, S3–S11 (2010)
28. Y. Liu, Y. He, Effect of blood glucose excursions on the risk of diabetic retinopathy in type 2 diabetes. In: 2011 Diabetes Conference: 71st scientific sessions of the American Diabetes Association, San Diego (Abstract) (2011)
29. M. Barbieri, M.R. Rizzo, R. Marfella, V. Boccardi, A. Esposito, A. Pansini, G. Paolisso, Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors. Atherosclerosis 227, 349–354 (2013)
30. I. Chiodini, G. Adda, A. Scillitani, F. Coletti, V. Morelli, S. Di Lembo, P. Epaminonda, B. Masserini, P. Beck-Peccoz, E. Orsi, B. Ambrosi, M. Arosio, Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care 30, 83–88 (2007)